Table 2 Operative characteristics, PACU variables and cumulative opioid consumption
TEA/PCIA Group | TEA Group | P | |
|---|---|---|---|
Operation time (min) | 267 [211 to 334] | 247 [195 to 348] | 0.694 |
Intraoperative sufentanil consumption (ug) | 28.5 ± 6.2 | 29.1 ± 8.4 | 0.716 |
Intraoperative fluid intake (mL) | 3250 [2700 to 3700] | 3250 [2475 to 5025] | 0.955 |
Intraoperative blood loss (mL) | 300 [112.5 to 475] | 225 [100 to5 25] | 0.705 |
Blood transfusion, n (%) | 12 (27.3) | 12 (28.6) | 0.893 |
PACU length of stay (min) | 97.9 ± 40.4 | 104.0 ± 34.8 | 0.513 |
PACU complications, n (%) | 6 (13.6) | 8 (19) | 0.952 |
Pain, n (%) | 2 (4.5) | 2 (4.8) | — |
Dysphoria, n (%) | 1 (2.3) | 1 (2.4) | — |
Shiver, n (%) | 3 (6.8) | 3 (7.1) | — |
Hypertension, n (%) | 0 (0) | 1 (2.4) | — |
Pain and dysphoria, n (%) | 0 (0) | 1 (2.4) | — |
Cumulative opioid Consumption (mg) | 41.48 [26.34 to 66.85] | 38.64 [29.19 to 42.00] | 0.109 |